Also trades as: BRKR (NASDAQ) · $vol 135M

$446.32

+20.61 (+4.84%)

Weekly Expected Move ±4.9%

$383 $404 $424 $445 $466

NASDAQ · Healthcare · Medical - Devices · Tech Score Neutral · Power 37 · $9.3B mcap · 104M float · 0.0061% daily turnover · Short 73% of daily vol

Credit Risk of going bust: higher than 59% of companies Debt: 17.2% of company value Bonds: none of note held by US funds details ▾

Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $10.76 (down 98%), Bruker Corporation would be worth roughly what it owes.
Total debt $1.92B against a stock market value of $9.25B.
Distance to default 4.30 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.01B (short-term plus half of long-term), stock volatility 57.2%; Altman Z 2.85. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Income Trends

Revenue

$3.4B +2.1% ▲

5Y CAGR: +11.6%

Gross Profit

$1.6B -5.0% ▼

5Y CAGR: +10.8%

Operating Income

$217M -14.4% ▼

5Y CAGR: -2.7%

Net Income

-$9M -107.6% ▼

EPS (Diluted)

$-0.15 -119.7% ▼

EBITDA

$288M -34.5% ▼

5Y CAGR: -2.2%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$2.4B	$2.5B	$3.0B	$3.4B	$3.4B
YoY Growth	+21.7%	+4.7%	+17.1%	+13.6%	+2.1%
Cost of Revenue	$1.2B	$1.2B	$1.5B	$1.7B	$1.9B
Gross Profit	$1.2B	$1.3B	$1.5B	$1.6B	$1.6B
Gross Margin	50.0%	51.6%	51.0%	49.0%	45.6%
R&D Expenses	$221M	$236M	$295M	$376M	$395M
SG&A Expenses	$562M	$607M	$729M	$894M	$884M
Operating Expenses	$796M	$873M	$1.1B	$1.4B	$1.4B
Operating Income	$413M	$433M	$437M	$253M	$217M
Operating Margin	17.1%	17.1%	14.7%	7.5%	6.3%
Interest Expense	$14M	$16M	$16M	$48M	$46M
Income Before Tax	$394M	$415M	$546M	$205M	$21M
Tax Expense	$113M	$116M	$118M	$91M	$29M
Net Income	$277M	$297M	$427M	$113M	-$9M
Net Margin	11.5%	11.7%	14.4%	3.4%	-0.3%
EPS (Diluted)	$1.81	$1.99	$2.90	$0.76	$-0.15
EBITDA	$497M	$519M	$676M	$439M	$288M
Shares Outstanding	153M	149M	147M	150M	152M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$864M	$980M	$801M	$797M	$860M	$977M	$823M	$838M
Cost of Revenue	$446M	$486M	$410M	$440M	$474M	$528M	$434M	$422M
Gross Profit	$419M	$493M	$391M	$358M	$386M	$449M	$389M	$416M
Gross Margin	48.4%	50.4%	48.8%	44.9%	44.9%	46.0%	47.3%	49.6%
R&D Expenses	$98M	$104M	$97M	$100M	$98M	$100M	$101M	$94M
SG&A Expenses	$239M	$237M	$225M	$231M	$227M	$247M	$242M	$239M
Operating Expenses	$351M	$421M	$359M	$346M	$319M	$337M	$344M	$481M
Operating Income	$68M	$72M	$32M	$12M	$67M	$112M	$45M	-$65M
Operating Margin	7.9%	7.4%	4.0%	1.5%	7.8%	11.4%	5.5%	-7.8%
Interest Expense	$12M	$16M	$13M	$16M	$20M	$11M	$12M	$0
Income Before Tax	$55M	$55M	$26M	$1M	-$73M	$67M	$18M	-$41M
Tax Expense	$15M	$41M	$9M	-$3M	-$14M	$38M	$2M	$14M
Net Income	$41M	$14M	$17M	$8M	-$60M	$26M	$14M	-$52M
Net Margin	4.7%	1.4%	2.2%	1.0%	-6.9%	2.7%	1.7%	-6.2%
EPS (Diluted)	$0.27	$0.09	$0.11	$0.05	$-0.41	$0.10	$0.02	$-0.41
EBITDA	$118M	$125M	$89M	$72M	$3M	$138M	$89M	$17M
Shares Outstanding	152M	152M	152M	152M	152M	152M	153M	152M

BRKRP NASDAQ

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet